OCUL
Ocular Therapeutix
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
OCUL fundamentals
Ocular Therapeutix (OCUL) expects to report earnings on Aug 6, 2025, with estimated revenue of 13.12M (YoY -20.20%), and EPS at -0.35 (YoY -34.62%).
Revenue estimate / YoY
13.12M
-20.20%
EPS estimate / YoY
-0.35
-34.62%
Report date
Aug 6, 2025
EPS
Revenue
Revenue & Expenses
OCUL has released its 2025 Q1 earnings report, with revenue of 10.70M, reflecting a YoY change of -27.59%, and net profit of -64.05M, showing a YoY change of 1.23%. The Sankey diagram below clearly presents OCUL's revenue sources and cost distribution.
Key Indicators
Ocular Therapeutix (OCUL) key financial stats and ratios, covering profitability, financial health, and leverage.
Ocular Therapeutix (OCUL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Ocular Therapeutix (OCUL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Ocular Therapeutix (OCUL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Ocular Therapeutix (OCUL) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Ocular Therapeutix (OCUL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Ocular Therapeutix’s revenue and profit?What is Ocular Therapeutix’s latest dividend and current dividend yield?What guidance did Ocular Therapeutix’s management provide for the next earnings period? What is Ocular Therapeutix’s gross profit margin?Did Ocular Therapeutix beat or miss consensus estimates last quarter?What does Ocular Therapeutix do and what are its main business segments?What were the key takeaways from Ocular Therapeutix’s earnings call?What is the revenue and EPS growth rate for Ocular Therapeutix year over year?